Dermalux is a non-invasive treatment that uses the most clinically proven wavelengths to energise cells and trigger the skins natural rejuvenating and healing processes to treat a wide range of conditions.

There is no risk of irritation, side effects or down time that may be associated with more invasive procedures. There have been no reported side effects in over 3,000 published clinical studies. However, it is important to be aware that photosensitive medications or health conditions may be contraindicated to the LED treatment due to increased sensitivity to light exposure.

Yes. Dermalux has one of the highest safety profiles of any skin care treatment. It does not generate heat or UV wavelengths so cannot damage skin tissue or create photosensitivity. It is clinically proven to be safe for all skin types and the most sensitive skin conditions.

Dermalux is a relaxing, pain free experience with evidenced wellbeing effects. The treatment does not generate heat but a feeling of natural warmth is common due to the increase in blood circulation.

The number of treatments required for optimum results is subject to a number of factors including indication and severity, age and lifestyle. An initial course of 8 to 12 sessions is generally recommended for all conditions. Treatments taken in quick succession will generally achieve faster results, such as 2-3 per week.

Results can last for several months following a course of Dermalux treatments subject to the indication. However, regular maintenance treatments are advised to extend results as part of an on-going skin health programme.

We recommend a water based topical that absorbs easily to avoid reflection of the beneficial light. Avoid anything with a high concentration of active ingredients which may be applied immediately after the LED treatment. For very sensitive or problem skin conditions, LED should be applied to cleansed skin only without any topical product to avoid the risk of adverse response.

No.Vitamin D production is triggered by exposure to UVB light which converts cholesterol found naturally in the body to vitamin D3.

No. Demalux does not use any wavelengths in the UV spectrum. Our LED’s have a very narrow nanometre tolerance to ensure they only emit the required peak wavelength.

Light is a powerful energy which is made up of wavelengths ranging from very short gamma rays to very long radio waves. The human eye has evolved to detect wavelengths between 400nm and 700nm as colour. We see this as the rainbow ranging from blue through to red light. We do not see UV wavelengths which range up to 390nm and at the other end of the electromagnetic spectrum, we do not detect Near Infrared wavelengths at around 800nm plus. NIR is a very powerful wavelength even though we cannot see it.

Absolutely. As we don’t see NIR light, it is easy to underestimate the amazing therapeutic benefits. NIR is the wound healing wavelength. It accelerates repair and has powerful calming and soothing benefits for inflammatory and problem skin conditions. It is also proven for pain relief.

We do not recommend using the Dermalux treatment on any client who is currently undergoing medical treatment for cancer. Once the client has been signed off by the oncologist or doctor, it is safe to proceed. Dermalux can be used on clients who have previously had cancer.

Even though the Dermalux treatment is very safe, our devices have not been tested on pregnant women therefore the risk is unknown. Treatment will be at the discretion of the skin care practitioner. It is safe to use on clients who are breast feeding.

Those with the following medical condition will be unsuitable for Dermalux LED treatment: epilepsy or seizures triggered by light (if no seizure for at least 5 years may be suitable if written consent is obtained); porphyria; lupus erythematous; photosensitive eczema; hypomelanism (albinism); active cancers (full remission is safe, partial remission medical consent required) Certain medications may run risk of a light sensitive reaction so any clients taking these medications may be contraindicated from receiving LED treatment unless they have written medical consent (with some medication it is possible to have LED 1 week after medication has ceased in many cases): certain antibiotics; chemotherapy, rheumatoid arthritis and psoriasis medication (e.g. methotrexate); neuroleptic & antipsychotic medication (haloperidol, chlorpromazine, trifluoperazine); anti-arrhythmic & heart conditions (amiodarone); retinoids – oral & topical (isotretinoin; roaccutane); Any clients who have been taking non-steroidal anti-inflammatory drugs-NSAIDs (naproxen; celecoxib) for less than 7 days may require additional Dermalux LED treatments to reach desired result. Clients who are pregnant will be required to obtain medical consent before treatment; this is because Dermalux LED systems have not been tested on pregnant women and therefore risk is unknown. ​ Clients on anti-arthritic medication (auranofin; azathioprine) are unsuitable for Dermalux LED treatment Precautions Those with the following: Eye disease or conditions & medication or treatment (medical consent may be required) Light induced migraines St Johns Wart Recent introduction of new skincare Under 16 years old Those who smoke Use sunbeds or have regular sun exposure may require additional Dermalux LED treatments to reach desired result.